Skip to main content
logo
Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
3.765
+0.035 (0.94%)
Aug 10, 2026, 10:06 AM EDT - Market open

Pyxis Oncology Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
13.8613.8616.15---
Revenue Growth
--14.17%----
Gross Profit
11.4711.4715.67---
Operating Income
-85.87-84.42-89.46-82.2-123.48-69.72
Net Income
-81.74-79.62-77.33-73.79-120.72-75.98
Earnings Per Share
-1.31-1.28-1.32-1.85-3.65-8.95
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
41.0266.86126.93119.3179.29274.74
Total Debt
18.2618.6720.221.3318.920.17
Net Cash (Debt)
22.7648.18106.7397.97160.37274.57
Net Cash Growth
-73.41%-54.85%8.95%-38.91%-41.59%3661.23%
Net Cash Per Share
0.360.781.832.464.8532.33

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-66.97-63.5-57.67-70.71-89.34-35.33
Capital Expenditures
--0.01-0.24-6.73-6.4-0.54
Free Cash Flow
-66.97-63.51-57.91-77.44-95.73-35.87
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
82.77%82.77%97.06%---
Operating Margin
-619.61%-609.18%-554.07%---
Pretax Margin
-411.87%-564.55%-492.35%---
Profit Margin
-413.91%-554.55%-505.75%---
FCF Margin
-483.24%-458.30%-358.66%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
17.285.205.79---